Home > Healthcare & Medical Devices > Pelvic Floor Electric Stimulator Market
Pelvic Floor Electric Stimulator Market size was valued at USD 221.3 million in 2022 and is estimated to account for USD 640 million by 2032. A pelvic floor electric stimulator is a medical device used to strengthen and rehabilitate the pelvic floor muscles.
To get more details on this report: Request Free Sample PDF
The pelvic floor muscles support the bladder, uterus, and rectum, and weakening of these muscles can lead to issues such as urinary incontinence and pelvic organ prolapse. The stimulator delivers mild electrical impulses to the pelvic floor muscles through small electrodes, causing them to contract and relax rhythmically through the process of electrical muscle stimulation (EMS) or neuromuscular electrical stimulation (NMES).
Urinary incontinence is a widespread condition that affects millions of people, particularly women, worldwide. Several factors contribute to its prevalence, including pregnancy and childbirth, menopause, obesity, and certain medical conditions. As the population ages and the incidence of risk factors increases, the number of individuals experiencing urinary incontinence is on the rise. For instance, according to a report from the National Library of Medicine, which is part of the National Institutes of Health (NIH), approximately 423 million individuals aged 20 years and older worldwide experience some form of urinary incontinence. Additionally, healthcare organizations, patient advocacy groups, and government agencies have collaborated on awareness campaigns to destigmatize these conditions and encourage people to seek help.
Report Coverage | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022: | USD 221.3 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 11.3% |
2032 Value Projection: | USD 640 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 254 |
Tables, Charts & Figures: | 357 |
Segments covered: | Product Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
To get more details on this report: Request Free Sample PDF
During the COVID-19 pandemic, the pelvic floor electric stimulator market experienced a negative impact initially. Many non-urgent treatments for pelvic floor disorders were postponed or cancelled to prioritize COVID-19 patients and conserve healthcare resources. Additionally, consumer spending on non-essential products, including medical devices including pelvic floor electric stimulators, declined as people focused on essential goods and services amid uncertain economic conditions. Increased awareness about pelvic floor disorders and available treatments, along with the adoption of telehealth and remote monitoring.
Aging is a major risk factor for pelvic floor disorders, as the muscles in the pelvic region weaken over time. For instance, according to the World Health Organization (WHO), the proportion of people aged 60 years or over is projected to increase significantly by 2030, with one in six individuals falling within this age group. Furthermore, between 2020 and 2050, the number of individuals aged 80 years or older is projected to triple, reaching a staggering 426 million.
Additionally, patients are increasingly seeking non-invasive or minimally invasive treatment options for various medical conditions. These devices offer a conservative and self-administered approach that allows patients to take control of their treatment at homecare settings.
To get more details on this report: Request Free Sample PDF
The pelvic floor electric stimulator market by product type is categorized into mobile and fixed. The mobile segment garnered USD 142.4 million revenue size in the year 2022. Mobile stimulators offer convenience and portability, enabling users to discreetly perform pelvic floor exercises anywhere they go. This smart home healthcare treatment option enhances accessibility, especially for individuals residing in remote areas. The presence of advanced features, such as smartphone connectivity and personalized tracking, engages users and motivates them to maintain consistent usage. Additionally, increasing penetration of smartphones and consumer preference for non-invasive solutions.
To get more details on this report: Request Free Sample PDF
Based on application, the pelvic floor electric stimulator market is segmented into urinary incontinence, neurodegenerative diseases, and sexual dysfunction. The urinary incontinence segment garnered USD 176.3 million revenue size in the year 2022. The increasing prevalence of urinary incontinence, particularly among the aging population base, has driven the demand for effective and non-invasive treatment options. Patients' preference for conservative solutions, along with the endorsement of pelvic floor electric stimulators by healthcare professionals. As more individuals seek convenient and efficient ways to manage urinary incontinence and improve their quality of life, the demand for pelvic floor electric stimulators.
Based on end-use, the pelvic floor electric stimulator market is segmented into hospitals, clinics, home care settings, and others. The hospitals segment accounted for over 52.4% market share in the year 2022.
Hospitals play a crucial role as specialized treatment facilities, offering comprehensive pelvic floor health services, including pelvic floor electrical stimulation, administered by skilled healthcare professionals. Moreover, a vast patient pool, the availability of improved technology, and attractive government initiatives.
U.S. pelvic floor electric stimulator market accounted for USD 84.9 million revenue size in 2022 due to the increasing geriatric population base along with the rising incidence of chronic diseases. As per the World Health Organization (WHO) report urinary incontinence risk in older individuals is influenced by multiple chronic conditions such as Parkinson's disease, diabetes mellitus, dementia, prostatic cancer, stroke, chronic obstructive pulmonary disease (COPD), and arthritis. For instance, according to a U.S. Census Bureau report, the number of people aged 65 years and older is projected to reach around 78.0 million by the year 2035. Additionally, the Parkinson's Foundation reports that approximately 60,000 individuals receive a Parkinson's disease diagnosis annually in the U.S.
Some of the eminent market participants operating in the pelvic floor electric stimulator market include Zynex Inc, TensCare Ltd, Verity Medical Ltd, InControl Medical, The Prometheus Group, Laborie, Inc, Athena Feminine Technologies, Renovia Inc, Nidd Valley Medical Ltd and Everyway Medical Instruments Co., Ltd, among others.
Click here to Buy Section of this Report
By Product Type (USD Million & Units)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries: